Drug Company and Conflict of Interest

Medpage’s Friday Feedback on Pradaxa quotes Dr. Patrick Lyden’s comment about the British Medical Journal’s concern over Pradaxa safety when he says it “has no clinical relevance whatsoever”. This would be more convincing if Dr.Lyden hadn’t been a speaker and consultant for Boehringer Ingelheim, the drug’s manufacturer and if B.I. hadn’t just agreed to pay $650 million to settle a lawsuit involving thousand of cases including over 1000 deaths rather than submit to expert disclosure and trial.

<http://www.nytimes.com/2014/05/29/business/international/german-drug-company-to-pay-650-million-to-settle-blood-thinner-lawsuits.html>

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s